FR941117-2-00044 FR941117-2-00038 Food and Drug Administration [Docket No. 94N&hyph;0219] Lemmon Co., et al.; Withdrawal of Approval of NADA's AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADA's) held by Lemmon Co., Banner Pharmacaps, Inc., and Nutra-Blend Corp. The sponsors requested the withdrawals of approval. In a final rule published elsewhere in this issue of the Federal Register , FDA is amending the regulations by removing the entries which reflect approval of the NADA's. EFFECTIVE DATE: November 28, 1994. FOR FURTHER INFORMATION CONTACT: Mohammad I. Sharar, Center for Veterinary Medicine (HFV&hyph;216), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;0749. SUPPLEMENTARY INFORMATION: FDA is withdrawing approval of three NADA's on the written request of the following sponsors: Lemmon Co., 650 Cathill Rd., Sellersville, PA 18960, is the sponsor of NADA 65&hyph;467 that provides for the use of Tetracycline Hydrochloride Capsules in dogs for the treatment of bacterial gastroenteritis and urinary tract infections. Lemmon Co. requested, in its letter of May 2, 1994, that FDA withdraw approval of NADA 65&hyph;467 because the firm no longer manufactures or markets the product. Banner Pharmacaps, Inc. (formerly Pharmacaps, Inc.), P.O. Box 547, 1111 Jefferson Ave., Elizabeth, NJ 07207, is the sponsor of NADA 119&hyph;844 that provides for the use of Dichlorophene/Toluene Capsules in dogs and cats as an anthelmintic. Banner Pharmacaps, Inc., requested, in its letter of April 20, 1994, that FDA withdraw approval of NADA 119&hyph;844 because the firm no longer manufactures or markets the product. Nutra-Blend Corp., Rt. 7, Box 192A, Neosho, MO 64850, is the sponsor of NADA 129&hyph;160 that provides for the manufacture of a Type B medicated feed containing 0.6 gram of hygromycin B per pound. This approved NADA is not required for the firm to manufacture a Type B medicated feed containing 0.6 gram of hygromycin B per pound. Accordingly, in a letter dated March 18, 1994, the firm requested that FDA withdraw the approval for NADA 129&hyph;160. Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with ยง514.115 Withdrawal of approval of applications (21 CFR 514.115), notice is given that approval of NADA's 65&hyph;467, 119&hyph;844, and 129&hyph;160, and all supplements and amendments thereto is hereby withdrawn, effective November 28, 1994. In a final rule published elsewhere in this issue of the Federal Register , FDA is amending 21 CFR 520.2345a, 21 CFR 520.580, 21 CFR 510.600(c)(1) and (c)(2), and 21 CFR 558.274 to reflect the withdrawal of approval of these NADA's. Dated: November 8, 1994. Stephen F. Sundlof, Director, Center for Veterinary Medicine. [FR Doc. 94&hyph;28332 Filed 11&hyph;16&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
